Upcoming Workshops
For Multiple Myeloma
Past workshops
For All Cancers
- Clinical Trials: How They Transform the Treatment of Cancer
- Clinical Trials: How They Transform the Treatment of Cancer
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Clinical Trials: How They Transform the Treatment of Cancer
- Update on Clinical Trials: How They Work
- Trends in Oncology and Treatment Planning: What You Need to KnowPart I of Life with Cancer: A Guide to Getting the Best Care
For Acute Lymphoblastic Leukemia
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Update from the 2021 American Society of Hematology (ASH) Annual Meeting
For Acute Myeloid Leukemia
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Update from the 2021 American Society of Hematology (ASH) Annual Meeting
For Basal Cell Cancer
For Bladder Cancer
For Bone Cancer
For Brain Cancer
For Breast Cancer
- Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 46th Annual San Antonio Breast Cancer Symposium (SABCS)Part II of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
- The Benefits of Clinical Trials for Triple Negative Breast Cancer
- Living with Breast Cancer - 46th Annual San Antonio Breast Cancer SymposiumPart I of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
- Metastatic Breast Cancer: Treatment Updates
- Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part I of Highlights from the 2023 American Society of Clinical Oncology Meeting
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Updates from the 45th Annual San Antonio Breast Cancer Symposium on Triple Negative Breast Cancer
- The Benefits of Clinical Trials for Triple Negative Breast Cancer
- Metastatic Triple Negative Breast CancerPart I of Living with Metastatic Triple Negative Breast Cancer
- Metastatic Breast Cancer: Treatment Updates
- HER2-Positive Metastatic Breast Cancer: What’s New in Treatment & Quality-of-Life
- The Role of Radiation Therapy in the Treatment of Breast Cancer
- The Benefits of Clinical Trials for Triple Negative Breast Cancer
- HER2-Positive Metastatic Breast Cancer: New Therapies
- Metastatic Breast Cancer: Treatment Updates
- The Benefits of Clinical Trials for Triple Negative Breast Cancer
For Chronic Lymphocytic Leukemia
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Chronic Lymphocytic Leukemia: Current Treatment PerspectivesPart II of Living with Chronic Lymphocytic Leukemia
- Update from the 2021 American Society of Hematology (ASH) Annual Meeting
For Chronic Myelogenous Leukemia
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Update from the 2021 American Society of Hematology (ASH) Annual Meeting
For Colorectal Cancer
- Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
- Advances in the Treatment of Colorectal Cancer
- Colorectal Cancer Treatment: Progress and Advances
- Colorectal Cancer Treatment: Progress & Advances
- Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart II of Equity. Every Patient. Every Day. Everywhere.
For Cutaneous T-Cell Lymphoma
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Update from the 2021 American Society of Hematology (ASH) Annual Meeting
For Diffuse Large B-Cell Lymphoma
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Diffuse Large B-Cell Lymphoma (DLBCL) Updates
- Update from the 2021 American Society of Hematology (ASH) Annual Meeting
For Follicular Lymphoma
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Update from the 2021 American Society of Hematology (ASH) Annual Meeting
For Head and Neck Cancer
- Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part I of Highlights from the 2023 American Society of Clinical Oncology Meeting
- Oral, Head and Neck Cancer: Treatment Updates
- Oral, Head & Neck Cancer: Treatment Update
For Hodgkin Lymphoma
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Update from the 2021 American Society of Hematology (ASH) Annual Meeting
For Leukemia
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Chronic Lymphocytic Leukemia: Current Treatment PerspectivesPart II of Living with Chronic Lymphocytic Leukemia
- Update from the 2021 American Society of Hematology (ASH) Annual Meeting
- Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart II of Equity. Every Patient. Every Day. Everywhere.
For Liver Cancer
For Lung Cancer
- Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
- Update on Small Cell Lung CancerPart I of Living with Small Cell Lung Cancer
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Non-Small Cell Lung Cancer: Biomarker Testing & Treatment TrendsPart II of Living with Non-Small Cell Lung Cancer
- What’s New in Diagnostic Technologies for People Living with Small Cell Lung CancerPart II of Living with Small Cell Lung Cancer
- Genomic Testing and Current Trends in the Treatment of Non-Small Cell Lung CancerPart III of Living with Non-Small Cell Lung Cancer
- Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart II of Equity. Every Patient. Every Day. Everywhere.
For Lymphoma
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Diffuse Large B-Cell Lymphoma (DLBCL) Updates
- Update from the 2021 American Society of Hematology (ASH) Annual Meeting
- Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart II of Equity. Every Patient. Every Day. Everywhere.
For Mantle Cell Lymphoma
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Update from the 2021 American Society of Hematology (ASH) Annual Meeting
For Marginal Zone Lymphoma
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Update from the 2021 American Society of Hematology (ASH) Annual Meeting
For Melanoma
- Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart II of Equity. Every Patient. Every Day. Everywhere.
For Mesothelioma
For Metastatic Breast Cancer
- Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 46th Annual San Antonio Breast Cancer Symposium (SABCS)Part II of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
- The Benefits of Clinical Trials for Triple Negative Breast Cancer
- Living with Breast Cancer - 46th Annual San Antonio Breast Cancer SymposiumPart I of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
- Metastatic Breast Cancer: Treatment Updates
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Updates from the 45th Annual San Antonio Breast Cancer Symposium on Triple Negative Breast Cancer
- Metastatic Triple Negative Breast CancerPart I of Living with Metastatic Triple Negative Breast Cancer
- Metastatic Breast Cancer: Treatment Updates
- HER2-Positive Metastatic Breast Cancer: What’s New in Treatment & Quality-of-Life
- The Role of Radiation Therapy in the Treatment of Breast Cancer
- The Benefits of Clinical Trials for Triple Negative Breast Cancer
- HER2-Positive Metastatic Breast Cancer: New Therapies
- Metastatic Breast Cancer: Treatment Updates
For Multiple Myeloma
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- Progress in the Treatment of Multiple MyelomaPart I of Living with Multiple Myeloma
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- Progress in the Treatment of Multiple Myeloma
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Update from the 2021 American Society of Hematology (ASH) Annual Meeting
- Progress in the Treatment of Multiple Myeloma
For Myelodysplastic Syndromes
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Update from the 2021 American Society of Hematology (ASH) Annual Meeting
- Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart II of Equity. Every Patient. Every Day. Everywhere.
For Myeloproliferative Neoplasms
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Update from the 2021 American Society of Hematology (ASH) Annual Meeting
- Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart II of Equity. Every Patient. Every Day. Everywhere.
For Non-Hodgkin Lymphoma
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Update from the 2021 American Society of Hematology (ASH) Annual Meeting
For Ovarian Cancer
For Pancreatic Cancer
- Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
- Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart II of Equity. Every Patient. Every Day. Everywhere.
For Peripheral T-Cell Lymphoma
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Update from the 2021 American Society of Hematology (ASH) Annual Meeting
For Prostate Cancer
- Metastatic Prostate Cancer: Current Treatment AdvancesPart I of Living with Metastatic Prostate Cancer
- Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part I of Highlights from the 2023 American Society of Clinical Oncology Meeting
For Sarcoma
For Skin Cancer
For Small Lymphocytic Lymphoma
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Update from the 2021 American Society of Hematology (ASH) Annual Meeting
For Squamous Cell Cancer
For Triple Negative Breast Cancer
- Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 46th Annual San Antonio Breast Cancer Symposium (SABCS)Part II of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
- The Benefits of Clinical Trials for Triple Negative Breast Cancer
- Living with Breast Cancer - 46th Annual San Antonio Breast Cancer SymposiumPart I of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
- Metastatic Breast Cancer: Treatment Updates
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Updates from the 45th Annual San Antonio Breast Cancer Symposium on Triple Negative Breast Cancer
- The Benefits of Clinical Trials for Triple Negative Breast Cancer
- Metastatic Triple Negative Breast CancerPart I of Living with Metastatic Triple Negative Breast Cancer
- Metastatic Breast Cancer: Treatment Updates
- HER2-Positive Metastatic Breast Cancer: What’s New in Treatment & Quality-of-Life
- The Role of Radiation Therapy in the Treatment of Breast Cancer
- The Benefits of Clinical Trials for Triple Negative Breast Cancer
- HER2-Positive Metastatic Breast Cancer: New Therapies
- Metastatic Breast Cancer: Treatment Updates
- The Benefits of Clinical Trials for Triple Negative Breast Cancer